Pharmaceutical News

RSS

Antibiotic Resistance: The Patient Perspective

We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.

From Bionow 6 May 2020

UTA is developing supply chain to rapidly deliver COVID-19 drugs to Texas’ underserved patients

Working with artificial intelligence, a University of Texas at Arlington researcher is developing a rapid-response supply chain designed to quickly deliver COVID-19 medications, once they are available, to vulnerable urban populations in Texas.

6 May 2020

Long-term buprenorphine treatment can improve health care outcomes

A study at Columbia University Mailman School of Public Health found that long-term buprenorphine treatment is associated with improvements in health care outcomes.

6 May 2020

AMP publishes evidence-based recommendations to standardize clinical genotyping tests for warfarin response

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus, evidence-based recommendations to aid in the design, validation and interpretation of clinical genotyping tests for the prediction of warfarin response.

6 May 2020

Study finds two FDA-approved drugs are promising against COVID-19

Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for other illnesses, seem promising.

5 May 2020

Study finds intake of BioCell Collagen decreases common signs of photoaging

Building on an extensive body of research on the efficacy of BioCell Collagen®, a new published laboratory study finds that daily supplementation with the branded matrix reduced common signs of UVB-induced photoaging compared to the group that did not receive the supplement.

5 May 2020

Study defines new starting points for therapy and vaccine research on coronavirus

The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.

4 May 2020

New antibiotic fights drug-resistant bacteria without notable toxic side-effects

Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.

4 May 2020

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.

4 May 2020

Anti-malarial drug use for COVID-19 associated with increased risk of cardiac arrhythmias

Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died.

3 May 2020

Study shows no association between prices and clinical benefit of cancer drugs

Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit.

2 May 2020

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

In the United States, hepatocellular or liver cancer deaths have doubled since 1979. Hepatitis C virus is the leading cause of liver cancer.

30 Apr 2020

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a "magic bullet" to prevent and cure COVID-19. And the medicines can - if used rashly - have serious side effects.

30 Apr 2020

Innovative STM method may lead to new, purer pharmaceuticals

A research project led by chemists at the University of Warwick first used ultrahigh resolution scanning tunnelling microscopy to see the exact location of atoms and bonds within a molecule, and then employed these incredibly precise images to determine the interactions that bond molecules to one another.

30 Apr 2020

New study explores risks of inappropriate medications in older adults

"Potentially inappropriate medications (PIMs)" are treatments that sometimes pose risks that outweigh their benefits, particularly for people who are 65 or older.

30 Apr 2020

Re-establishing pharmaceutical chemical production in Europe in the wake of COVID-19

Over 80% of chemicals used to make pharmaceuticals sold in Europe originate from China or India, according to the European Fine Chemicals Group.

30 Apr 2020

Almost one-third of primary care physicians view medications as ineffective for treating opioid use disorder

A new survey of U.S. primary care physicians from researchers at Johns Hopkins Bloomberg School of Public Health found that nearly one-third, 32.9 percent, do not think treating opioid use disorder with medication is any more effective than treatment without medication.

30 Apr 2020

SU2C commends FDA’s approval of new cancer therapy

Stand Up To Cancer (SU2C) welcomed the recent Food and Drug Administration (FDA) approval this month of encorafenib in combination with cetuximab for patients with advanced BRAF-mutated colorectal cancer.

30 Apr 2020

Researchers test existing anti-inflammatory drug in COVID-19 patients

An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19, the pandemic disease caused by the novel coronavirus.

29 Apr 2020

Differences in reporting methods can over- or under-estimate the safety of drugs

An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.

29 Apr 2020

Pharmaceutical News

Antibiotic Resistance: The Patient Perspective

UTA is developing supply chain to rapidly deliver COVID-19 drugs to Texas’ underserved patients

Long-term buprenorphine treatment can improve health care outcomes

AMP publishes evidence-based recommendations to standardize clinical genotyping tests for warfarin response

Study finds two FDA-approved drugs are promising against COVID-19

Study finds intake of BioCell Collagen decreases common signs of photoaging

Study defines new starting points for therapy and vaccine research on coronavirus

New antibiotic fights drug-resistant bacteria without notable toxic side-effects

RA patients enrolled in Medicare plan face significant cost exposure on specialty drugs

Anti-malarial drug use for COVID-19 associated with increased risk of cardiac arrhythmias

Study shows no association between prices and clinical benefit of cancer drugs

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

Innovative STM method may lead to new, purer pharmaceuticals

New study explores risks of inappropriate medications in older adults

Re-establishing pharmaceutical chemical production in Europe in the wake of COVID-19

Almost one-third of primary care physicians view medications as ineffective for treating opioid use disorder

SU2C commends FDA’s approval of new cancer therapy

Researchers test existing anti-inflammatory drug in COVID-19 patients

Differences in reporting methods can over- or under-estimate the safety of drugs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News